ScholarWorks@SUNGKYUNKWAN UNIVERSITY: PARK, SE EUN

Detailed Information

PARK, SE EUN (박세은)

Medicine (Medicine)

Research Area

Tel
Homepage

ResearcherID ORCiD Scopus Google Scholar ID ResearchGate

Keyword

Diabetes mellitus:9||Insulin resistance:8||Diabetes:7||Nonalcoholic fatty liver disease:7||Obesity:6||Coronary artery calcification:6||Body mass index:5||Fatty liver:4||Exendin4:4||Atherosclerosis:4||Metabolic syndrome:4||Waist circumference:4||Insulinsecreting cells:3||AMPactivated protein kinases:3||obesity:3||Autophagy:3||Cardiovascular diseases:3||Cohort studies:3||Nonalcoholic fatty liver disease:3||metabolic syndrome:3||Prevalence:3||Osteoporosis:3||Thyroid:2||nonalcoholic fatty liver disease:2||Clusterin:2||Hypothyroidism:2||Genetic association:2||Incidence:2||risk factors:2||Inflammation:2||Endoplasmic reticulum stress:2||Vascular calcification:2||Adipocytes:2||Physical activity:2||type 2:2||Adiponectin:2||Coronary artery calcium score:2||Coronary artery disease:2||Lipolysis:2||body mass index:2||Lipoprotein(a):2||Renal insufficiency:2||Fatty acid oxidation:2||Heart failure:2||diabetes mellitus:2||SIRT1:2||Metabolic health:2||Sarcopenia:2||Mortality:2||Hepatocytes:2||AMPK:2||Bone metabolism:2||insulin resistance:2||Hyperthyroidism:2||Hypertriglyceridemia:2||Statin:2||ER stress:2||Glucagonlike peptide1 receptor:1||Glucolipotoxicity:1||Gluconeogenesis:1||Glucose tolerance:1||Glucose tolerance test:1||Glycated albumin:1||Glycated hemoglobin:1||Glycemia:1||Glycemic progression:1||Glycosylated hemoglobin:1||Growth hormonesecreting pituitary adenoma:1||HbA1c:1||HepG2 cells:1||Hepatic steatosis:1||Hepatokine:1||Hip fractures:1||Hyperinsulinemia:1||Hypertension:1||Hypertriglyceridemic waist phenotype:1||Hypertriglyericlemia:1||INTERNATIONAL PHYSICAL ACTIVITY QUESTIONNAIRE:1||Incident diabetes:1||Inorganic phosphate:1||Insulin:1||Insulin secretion and incident diabetes:1||Insulin signaling:1||Korean National Health Insurance Corporation:1||LC3II conversion:1||LXR:1||Lean mass:1||Lipid accumulation:1||Lipin1:1||Lowdensity lipoprotein cholesterol:1||METABOLIC EQUIVALENT TASK:1||MORTALITY:1||Metab:1||Mitochondria:1||NAD:1||National Health Programs:1||Nicotinamide:1||Nicotinic acid:1||NonObese older:1||Observational study:1||Osteoblast differentiation:1||PERK/eIF2α:1||PGC1 alpha:1||PHYSICAL ACTIVITY:1||PPAR alpha:1||Palmitic acid:1||Percutaneous coronary intervention:1||Perilipin:1||Persistence:1||Persistent:1||Pioglitazone:1||Polymorphism:1||Pooled Cohort Equation:1||Pooled cohort equation:1||Prediabetes:1||Prediabetic state:1||Progranulins:1||Progression:1||Prohibitin:1||Public health:1||RANKL:1||Receptor activator of nuclear factorkappa B ligand (RANKL):1||Retinopathy:1||Risk:1||Risk factors:1||SGLT2 inhibitor:1||SREBP1:1||SREBP1c:1||Screening:1||Secondary prevention:1||Selenoprotein P:1||Serum deprivation:1||Sex:1||Sirtuin:1||Smoking:1||Smoking cessation:1||Sodiumdependent glucose transporter 2:1||Sphingosine 1phosphate:1||Sphingosine kinase:1||Spinal fractures:1||Subclinical atherosclerosis:1||TSH:1||Thyroid neoplasms:1||Transferrin:1||Transient elastography:1||Tumor necrosis facto:1||Ty:1||Type 2 diabetes mellitus:1||VLDL assembly:1||Vascular smooth muscle cells:1||Vitamin D:1||Waistheight ratio:1||Weight:1||White blood cell count:1||abdominal obesity:1||adiponectin:1||albuminuria:1||atherogenic dyslipidaemia:1||autonomic nervous system:1||beige adipose tissue:1||betaCell:1||biomarker:1||body composition:1||bone:1||chronic:1||cilostazol:1||cohort study:1||comorbidity:1||coronary artery calcification:1||dipeptidyl peptidase4 inhibition:1||extracellular signalregulated kinases 1 and 2:1||fatty liver disease (FLD):1||gemigliptin:1||genetic association:1||glomerular filtration rate:1||glycaemic variability:1||glycemic variability:1||heart rate variability:1||hepatokine:1||hypertension:1||inflam:1||liver fibrosis:1||metabolic health:1||metabolomics:1||microbiota:1||mortality:1||myokine:1||nationwide populationbased study:1||neoplasms:1||parasympathetic nervous system:1||prediabetes:1||restoration:1||retinopathy:1||rosiglitazone:1||sympathetic nervous system:1||thyroid:1||thyroid cancer:1||thyroid hormone:1||thyroid hormones:1||thyroid neoplasms:1||tumor necrosis factoralpha:1||type 2 diabetes:1||visceral adiposity index:1||1:1||white adipose tissue:1||5anhydroglucitol:1||ANGPTL8:1||ATPbinding cassette transporter 1:1||Abdominal obesity:1||Acromegaly:1||Adipocytokine:1||Adipokine:1||Aging:1||Alanine aminotra:1||Alkaline phosphatase:1||Aortic calcification:1||Apoptosis:1||Arterial stiffness:1||Autophagy related protein 3:1||Bitter melon:1||Blood pressure:1||Body com:1||Body height:1||Body weight changes:1||Body weight maintenance:1||Cpeptide:1||Calcification:1||Cancer:1||Chaperone:1||Cholesterol HDL:1||Cholesterol LDL:1||Cholesterol guidelines:1||Chronic:1||Coronary artery:1||Coronary artery calcification (CAC):1||Coronary vessels:1||Daily calcium intake:1||Depression:1||Diabetes mellitus, type 2:1||Diabetic reti:1||Dietary cholesterol:1||Dulaglutide:1||ERAD:1||EXERCISE:1||Epidemiology:1||Exercise:1||Exercise benefit:1||Ezetimibe:1||FAM3A:1||FGF21:1||FGFRs:1||FOXO1:1||FT3/FT4 ratio:1||Fatty acidbinding protein4:1||Fatty liver disease:1||FetuinA:1||Fibrosis:1||Fractures:1||Framingham risk score:1||GLP 1 agonist:1||Glomerular filtration rate:1||

STATISTICS: Total View :0; Today View :0

RSS_1.0 RSS_2.0 ATOM_1.0

(03063) 25-2, SUNGKYUNKWAN-RO, JONGNO-GU, SEOUL, KOREAsamsunglib@skku.edu

Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.

Detailed Information

Keyword

BROWSE